Intercept Pharmaceuticals, Inc.
🏢 View company profile →62Patents
60Active
62Granted
53Portfolio score
Filing activity: Feb 21, 2002 → Apr 14, 2022 · 11 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7138390B2 | Steroids as agonists for FXR | Chemistry; Metallurgy | 45 | Expired |
| US9763964B2 | Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions | Chemistry; Metallurgy | 19 | Active |
| US10052337B2 | Compositions of obeticholic acid and methods of use | Chemistry; Metallurgy | 16 | Active |
| US9732116B2 | Preparation and uses of obeticholic acid | Chemistry; Metallurgy | 16 | Active |
| US7994352B2 | Process for preparing 3a(β)-7a(β)-dihydroxy-6a(β)-alkyl-5β-cholanic acid | Human Necessities | 14 | Active |
| US7786102B2 | Steroids as agonists for FXR | Chemistry; Metallurgy | 13 | Active |
| US7858608B2 | Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions | Chemistry; Metallurgy | 13 | Active |
| US7812011B2 | Steroid agonist for FXR | Human Necessities | 12 | Expired |
| US7932244B2 | Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions | Chemistry; Metallurgy | 12 | Active |
| US8377916B2 | Steroids as agonists for FXR | Chemistry; Metallurgy | 11 | Active |
| US9611289B2 | Farnesoid X receptor modulators | Chemistry; Metallurgy | 9 | Active |
| US8058267B2 | Steroids as agonists for FXR | Chemistry; Metallurgy | 9 | Active |
| US9498484B2 | Treatment of fibrosis using FXR ligands | Human Necessities | 7 | Active |
| US9238673B2 | Preparation and uses of obeticholic acid | Chemistry; Metallurgy | 7 | Active |
| US8114862B2 | TGR5 modulators and methods of use thereof | Chemistry; Metallurgy | 7 | Active |
| US8796249B2 | TGR5 modulators and methods of use thereof | Chemistry; Metallurgy | 5 | Active |
| US8546365B2 | Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions | Chemistry; Metallurgy | 4 | Active |
| US9243027B2 | TGR5 modulators and methods of use thereof | Chemistry; Metallurgy | 4 | Active |
| US8999964B2 | TGR5 modulators and methods of use thereof | Human Necessities | 4 | Active |
| US10532061B2 | Farnesoid X receptor modulators | Chemistry; Metallurgy | 3 | Active |
| US8445472B2 | TGR5 modulators and methods of use thereof | Chemistry; Metallurgy | 3 | Active |
| US9777038B2 | Process for preparing bile acid derivatives | Chemistry; Metallurgy | 3 | Active |
| US10800807B2 | TGR5 modulators and methods of use thereof | Chemistry; Metallurgy | 3 | Active |
| US8410083B2 | 23-substituted bile acids as TGR5 modulators and methods of use thereof | Chemistry; Metallurgy | 3 | Active |
| US9732117B2 | Steroids as agonists for FXR | Chemistry; Metallurgy | 3 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.